BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11849625)

  • 1. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children.
    Erbağci AB; Tarakçioğlu M; Coşkun Y; Sivasli E; Sibel Namiduru E
    Clin Biochem; 2001 Nov; 34(8):645-50. PubMed ID: 11849625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-alpha) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes].
    Głowińska B; Urban M
    Wiad Lek; 2003; 56(3-4):109-16. PubMed ID: 12923954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM).
    Karavanaki K; Karanika E; Georga S; Bartzeliotou A; Tsouvalas M; Konstantopoulos I; Fotinou A; Papassotiriou I; Karayianni C
    Endocr J; 2011; 58(12):1045-53. PubMed ID: 22033476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
    Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
    Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical investigation of gender-specific association between insulin resistance and inflammatory biomarkers in types 2 diabetic patients.
    Akash MSH; Rehman K; Liaqat A; Numan M; Mahmood Q; Kamal S
    Biomed Pharmacother; 2018 Oct; 106():285-291. PubMed ID: 29966972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes.
    Redondo MJ; Rodriguez LM; Haymond MW; Hampe CS; Smith EO; Balasubramanyam A; Devaraj S
    Pediatr Diabetes; 2014 Dec; 15(8):543-9. PubMed ID: 24978596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
    Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
    Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.
    Ha CY; Kim JY; Paik JK; Kim OY; Paik YH; Lee EJ; Lee JH
    Clin Endocrinol (Oxf); 2012 May; 76(5):674-82. PubMed ID: 21958081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship among serum cytokines, chemokine, nitric oxide, and leptin in children with type 1 diabetes mellitus.
    Lo HC; Lin SC; Wang YM
    Clin Biochem; 2004 Aug; 37(8):666-72. PubMed ID: 15302608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Levels of Salivary Cytokines in Diabetic and Nondiabetic Puerto Rican Children: A Case-control Pilot Study.
    López del Valle LM; Ocasio-López C; Steffen M
    Pediatr Dent; 2015; 37(1):30-4. PubMed ID: 25685970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between changes in inflammatory cytokines and the combination with hypertension in patients with type 2 diabetes mellitus.
    He Q; Dong M; Pan Q; Wang X; Guo L
    Minerva Endocrinol; 2019 Sep; 44(3):252-258. PubMed ID: 29687969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis.
    Karavanaki K; Kakleas K; Georga S; Bartzeliotou A; Mavropoulos G; Tsouvalas M; Vogiatzi A; Papassotiriou I; Karayianni C
    Clin Biochem; 2012 Nov; 45(16-17):1383-8. PubMed ID: 22584003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat meals induce systemic cytokine release without evidence of endotoxemia-mediated cytokine production from circulating monocytes or myeloid dendritic cells.
    Fogarty CL; Nieminen JK; Peräneva L; Lassenius MI; Ahola AJ; Taskinen MR; Jauhiainen M; Kirveskari J; Pussinen P; Hörkkö S; Mäkinen VP; Gordin D; Forsblom C; Groop PH; Vaarala O; Lehto M
    Acta Diabetol; 2015 Apr; 52(2):315-22. PubMed ID: 25182144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
    Dogan Y; Akarsu S; Ustundag B; Yilmaz E; Gurgoze MK
    Mediators Inflamm; 2006; 2006(1):59206. PubMed ID: 16864906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients.
    Satoh-Asahara N; Sasaki Y; Wada H; Tochiya M; Iguchi A; Nakagawachi R; Odori S; Kono S; Hasegawa K; Shimatsu A
    Metabolism; 2013 Mar; 62(3):347-51. PubMed ID: 23062489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes.
    Mohamed-Ali V; Armstrong L; Clarke D; Bolton CH; Pinkney JH
    J Intern Med; 2001 Nov; 250(5):415-21. PubMed ID: 11887976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus.
    Danielsson P; Truedsson L; Eriksson KF; Norgren L
    Vasc Med; 2005 Aug; 10(3):191-8. PubMed ID: 16235772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum IL-1, IL-2, TNFalpha and INFgamma levels of patients with type 1 diabetes mellitus and their siblings.
    Ozer G; Teker Z; Cetiner S; Yilmaz M; Topaloglu AK; Onenli-Mungan N; Yüksel B
    J Pediatr Endocrinol Metab; 2003 Feb; 16(2):203-10. PubMed ID: 12713258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of glucoregulation quality on C-reactive protein, interleukin-6 and tumor necrosis factor-alpha level in patients with diabetes type 1.
    Mitrović M; Ilić T; Stokić E; Paro JN; Naglić DT; Bajkin I; Icin T
    Vojnosanit Pregl; 2011 Sep; 68(9):756-61. PubMed ID: 22046880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.